Australia markets closed

Microba Life Sciences Limited (MAP.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1600-0.0100 (-5.88%)
At close: 03:30PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
Total revenue
5,420
5,420
4,689
Cost of revenue
2,742
2,742
2,323
Gross profit
2,678
2,678
2,366
Operating expenses
Research development
9,337
9,337
5,384
Selling general and administrative
8,502
8,502
9,114
Total operating expenses
22,908
22,908
18,638
Operating income or loss
-20,230
-20,230
-16,272
Interest expense
16.409
16.409
8.307
Total other income/expenses net
6,738
6,738
4,817
Income before tax
-12,675
-12,675
-11,461
Income tax expense
5.643
5.643
9.23
Income from continuing operations
-12,680
-12,680
-11,470
Net income
-12,680
-12,680
-11,470
Net income available to common shareholders
-12,680
-12,680
-11,470
Basic EPS
-0.04
-
-0.05
Diluted EPS
-0.04
-
-0.05
Basic average shares
332,990
-
236,375
Diluted average shares
332,990
-
236,375